FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6 through 35 months.
Sanofi Pasteur, the vaccine division of Sanofi, had the 0.5 mL dose, in addition to the 0.25 mL dose, available for the 2019-20 season for this expanded age range.
Tags:
Source: Sanofi Pasteur
Credit:
